Magdy Algowhary

Dr. Magdy Algowhary

Assiut University Heart Hospital, Assiut University, Asyūţ, Egypt
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in Heart
Verified
Journal Article
Closed access
PDF file
Leonardo De LucaLeonardo De Luca
Leonardo De Luca
Magdy AlgowharyMagdy Algowhary
Magdy Algowhary
BUBerat Uguz
Berat Uguz
DODinaldo C Oliveira
Dinaldo C Oliveira
VGVladimir Ganyukov
Vladimir Ganyukov
MVMonica Verdoia
Monica Verdoia
Objective The initial data of the International Study on Acute Coronary Syndromes - ST Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction in primary percutaneous coronary intervention procedures and higher in-hospital mortality during the initial phase of the pandemic as compared with the prepandemic period. The aim of the current study was to provide the final results of the registry, subsequently extended outside Europe with a larger inclusion period (up to June 2020) and longer follow-up (up to 30 days). Methods This is a retrospective multicentre registry in 109 high-volume primary percutaneous coronary intervention (PPCI) centres from Europe, Latin America, South-East Asia and North Africa, enrolling 16 674 patients with ST segment elevation myocardial infarction (STEMI) undergoing PPPCI in March/June 2019 and 2020. The main study outcomes were the incidence of PPCI, delayed treatment (ischaemia time >12 hours and door-to-balloon >30 min), in-hospital and 30-day mortality. Results In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio 0.843, 95% CI 0.825 to 0.861, p75 years) (p=0.015), and was not related to the peak of cases or deaths due to COVID-19. The heterogeneity among centres was high (p<0.001). Furthermore, the pandemic was associated with a significant increase in door-to-balloon time (40 (25–70) min vs 40 (25–64) min, p=0.01) and total ischaemia time (225 (135–410) min vs 196 (120–355) min, p<0.001), which may have contributed to the higher in-hospital (6.5% vs 5.3%, p<0.001) and 30-day (8% vs 6.5%, p=0.001) mortality observed during the pandemic. Conclusion Percutaneous revascularisation for STEMI was significantly affected by the COVID-19 pandemic, with a 16% reduction in PPCI procedures, especially among older patients (about 20%), and longer delays to treatment, which may have contributed to the increased in-hospital and 30-day mortality during the pandemic. Trial registration number NCT04412655.

16 October 2019 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
PDF file
HFHekma Saad Farghaly
Hekma Saad Farghaly
KMKotb Abbass Metwalley
Kotb Abbass Metwalley
DRDuaa Mohamed Raafat
Duaa Mohamed Raafat
Magdy AlgowharyMagdy Algowhary
Magdy Algowhary
GSGhada Mohamed Said
Ghada Mohamed Said
Background/Aims: Thyroid hormones (TSH) play a key role in the working of the cardiovascular system, with direct effects on cardiac function, vascular system, and atherosclerotic factors. Epicardial adipose tissue, the visceral fat of the heart, has emerged as a new cardiometabolic risk marker because of its close anatomical proximity to the myocardium and coronary artery. This study aimed to evaluate epicardial fat thickness (EFT) in children with subclinical hypothyroidism (SH) and its relation to early atherosclerotic changes. Methods: The study included 32 children with SH due to autoimmune thyroiditis and 32 healthy children matched for age and gender as control group. Patients and controls underwent anthropometric evaluation and measurement of fasting lipids, glucose, insulin, homeostasis model assessment for insulin resistance and high-sensitivity C-reactive protein (hs-CRP). TSH, free thyroxine (FT4 and FT3) and antithyroid autoantibodies (antithyroid peroxidase and thyroglobulin antibodies) were also measured. Conventional echo­cardiography was used to assess EFT. Noninvasive ultrasound was used to measure carotid intima-media thickness and brachial artery flow-mediated dilation (FMD) responses. Results: Compared to controls, patients had higher atherogenic index (AI) and hs-CRP (p = 0.001 for each). Conventional echocardiography revealed that patients with SH had higher EFT (p = 01) and significantly lower FMD response compared with the control (p = 0.001). In multivariate analysis, EFT values were significantly correlated with TSH (OR 1.2; 95% CI 1.04–1.34; p = 0.01), hs-CRP (OR 1.1; 95% CI 1.09–1.14; p = 0.001, AI (OR 1.6; 95% CI 1.17–2.03; p = 0.001), and FMD response (OR 2.4; 95% CI 1.14–2.53; p = 0.01). Conclusions: Our study demonstrated that EFT is higher in children with SH compared with controls and associated with FMD responses. Measurement of EFT by echocardiography in children with SH may help to identify those at high risk of developing subclinical atherosclerosis.


9 November 2023 in The Egyptian Heart Journal
Verified
Journal Article
Open access
PDF file
Magdy AlgowharyMagdy Algowhary
Magdy Algowhary
AFAhmed Farouk
Ahmed Farouk
HEHeba E. M. El-Deek
Heba E. M. El-Deek
GHGhada Hosny
Ghada Hosny
AAAhmed Ahmed
Ahmed Ahmed
TSTahia H. Saleem
Tahia H. Saleem
Background: Previous studies have reported conflicting results about the association of vitamin D (VD) level with coronary artery disease (CAD). We aimed to study the association of VD with atherosclerotic CAD in Egyptian individuals. Results: We prospectively enrolled 188 consecutive CAD patients with a median age of 55(50–62) years; 151(80.3%) were male. All patients were diagnosed by cardiac catheterization and were compared with 131 healthy controls. VD levels were measured in serum samples of all participants. Compared to controls, CAD patients had a significantly lower median VD level, 14.65 (9.25–21.45) versus 42.0 (32.0–53.0) ng/mL, p < 0.001. VD was correlated with the number of diseased coronary arteries and lipid profile (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides, p < 0.001 for each). By multivariate analyses, VD was an independent predictor of CAD [OR 1.22 (95% CI 1.07–1.4), p = 0.003, optimal cut-off value 30 ng/mL (AUC 0.92, sensitivity 81% and specificity 81.4%), p < 0.001], and the number of diseased coronary arteries, p < 0.001, especially three-vessel disease [OR 0.83 (95% CI 0.72–0.95), p = 0.008]. Conclusions: We have shown that low VD should be considered a non-traditional risk factor for CAD in Egyptian individuals. Low VD was correlated with coronary atherosclerosis, especially in patients with multivessel effects.

1 July 2021 in Atherosclerosis
Verified
Journal Article
Closed access
HFHekma Saad Farghaly
Hekma Saad Farghaly
KMKotb Abbass Metwalley
Kotb Abbass Metwalley
DRDuaa Mohamed Raafat
Duaa Mohamed Raafat
GSGhada Mohamed Saied
Ghada Mohamed Saied
MGMagda Farghali Gabri
Magda Farghali Gabri
Magdy AlgowharyMagdy Algowhary
Magdy Algowhary

14 June 2022 in International Journal of Cardiology
Verified
Journal Article
Closed access
TATarek A.N. Ahmed
Tarek A.N. Ahmed
EAEman Abbas
Eman Abbas
ABAhmed H. Bakr
Ahmed H. Bakr
SDSalwa R. Demitry
Salwa R. Demitry
Magdy AlgowharyMagdy Algowhary
Magdy Algowhary